glp-1 agonist dementia Frontiers GLP-1 receptor agonists show promise

Florin Despa (Department of Pharmacology, University of Kentucky) for sharing valuable insights into the preclinical and clinical actions of amylin in both animal models and humans

[DOI] [PubMed] [Google Scholar] 28.Heppner K.M., Kirigiti M., Secher A., Paulsen S.J., Buckingham R., Pyke C., Knudsen L.B., Vrang N., Grove K.L

Nutrition Screening As most individuals in the United States do not meet recommendations for healthy dietary patterns, 50 education regarding choosing nutrient dense foods and beverages is especially beneficial for patients taking GLP-1 agonist medications

This includes improving patient compliance, establishing nutritional priorities for weight maintenance following quitting, and fine-tuning combined or phased intensive lifestyle management techniques [85]

Most gastroparesis patients fit the ROME IV criteria for functional dyspepsia

One GLP-1RA, liraglutide, has been approved to treat obesity, and another, semaglutide, is in clinical trials